Clinical Trials Browser

INDUSTRY × Has results × ridaforolimus × Clear all

NCT00874731 2019-05-06

MK-8669-037

Phase 1 Completed

23 enrolled 14 charts

Neoplasm Metastasis

NCT01380184 2019-04-19

MK-8669-059

Phase 1 Completed

15 enrolled 15 charts

Neoplasms, Recurrence

NCT01605396 2019-03-25

MK-8669-064

Phase 2 Completed

80 enrolled 13 charts

Breast Neoplasms

NCT01431534 2019-03-01

MK-8669-056

Phase 1 Terminated

20 enrolled 10 charts

Other solid neoplasm

Solid Tumors

NCT00836927 2019-02-18

MK-8669-038

Phase 2 Terminated

7 enrolled 13 charts

Advanced Cancers

NCT01243762 2018-08-16

A Study of Dalotuzumab + MK-2206, Dalotuzumab + MK-0752, and Dalotuzumab + Ridaforolimus Combination Therapies in Participants With Advanced Cancer (MK-0646-027)

Phase 1 Terminated

47 enrolled 12 charts

GastrointestinalGynecologic

Fallopian Tube Neoplasms, Neoplasms, Ovarian Neoplasms, Colorectal Neoplasms